NIH Announces New Program to Develop Therapeutics for Rare and Neglected Diseases – 3
Narrator: This is NIH Health Matters.
Dr. Guttmacher: So we’re going to focus on rare and neglected diseases.
Narrator: Dr. Alan Guttmacher, at the National Human Genome Research Institute, explains that the aims of a new drug development program include evaluating each step of the process, and . . .
Dr. Guttmacher: To do the kinds of steps that are necessary. And toimprove the way those steps are done compared to how they’ve been done traditionally. To make them shorter steps, to make them less expensive steps so we can really develop new therapies for these rare and neglected diseases.
Narrator: It can take a dozen years and hundreds of millions of dollars to take a potential drug from discovery to the marketplace. Dr. Guttmacher says this program’s goal is to get new medications to people currently without treatment. For details, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.